EUVIMEDEUVIMED entdecken
Crossref

Engineered Magnetic Resonance Nanoprobes for Visualizing Tumor Programmed Cell Death Ligand 1 Level and Enhancing Synergistic Radio Immunotherapy

Xiao Sun iD, Yufang Gong iD, Haiyan Ge, Guiqi Ma, Tianxing Yang, Mengyao Mu, Le Zhang, Chenyu Wang, Bowen Shen, Xiaohui Dai, Zhengyan Wu iD, Xinyu Zhang und 2 weitere

ACS Nano · 2025

DOI: 10.1021/acsnano.5c04774 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Xiao Sun und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 25011…. Hauptthemen laut MEDLINE: B7-H1 Antigen, Radioimmunotherapy, Nanoparticles, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenRadioimmunotherapyNanoparticlesProgrammed Cell Death 1 ReceptorImmune Checkpoint InhibitorsNeoplasmsMagnetic Resonance ImagingRecombinant Fusion ProteinsMolecular ImagingApoptosisHumansGadoliniumPlatinumAnimalsMiceCell Line, TumorMice, Inbred C57BLFemale

Stichwörter der Autor:innen

MRIdimeric PD-L1 affibodyferroptosisnanoprobesradio-immunotherapy

Substanzen

B7-H1 AntigenRecombinant Fusion ProteinsProgrammed Cell Death 1 ReceptorImmune Checkpoint InhibitorsGadoliniumPlatinum

Autor:innen und Institutionen

  • Department of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China.
  • School of Chemistry and Pharmaceutical Engineering, Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250000, China.
  • Department of Radiology, Shengjing Hospital, China Medical University, Shenyang 110004, China.
  • Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China.
  • Tumor Research and Therapy Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China.

ORCID-Profile: Xiao Sun, Yufang Gong, Zhengyan Wu, Qing Fan

Förderung

  • Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • Shengjing Hospital
  • Collaborative Academic Innovation Project of Shandong Cancer Hospital
  • Shenyang High Level Innovative Talents Support Program

Zitieren

APA

Sun, X., Gong, Y., Ge, H., Ma, G., Yang, T., Mu, M., Zhang, L., Wang, C., Shen, B., Dai, X., Wu, Z., Zhang, X., Fan, Q., & Sun, H. (2025). Engineered Magnetic Resonance Nanoprobes for Visualizing Tumor Programmed Cell Death Ligand 1 Level and Enhancing Synergistic Radio Immunotherapy. ACS Nano. https://doi.org/10.1021/acsnano.5c04774

Vancouver

Sun X, Gong Y, Ge H, Ma G, Yang T, Mu M, et al. Engineered Magnetic Resonance Nanoprobes for Visualizing Tumor Programmed Cell Death Ligand 1 Level and Enhancing Synergistic Radio Immunotherapy. ACS Nano. 2025. doi:10.1021/acsnano.5c04774

BibTeX
@article{Sun2025,
  author = {Sun, Xiao and Gong, Yufang and Ge, Haiyan and Ma, Guiqi and Yang, Tianxing and Mu, Mengyao and Zhang, Le and Wang, Chenyu and Shen, Bowen and Dai, Xiaohui and Wu, Zhengyan and Zhang, Xinyu and Fan, Qing and Sun, Hongzan},
  title = {Engineered Magnetic Resonance Nanoprobes for Visualizing Tumor Programmed Cell Death Ligand 1 Level and Enhancing Synergistic Radio Immunotherapy},
  journal = {ACS Nano},
  year = {2025},
  doi = {10.1021/acsnano.5c04774}
}
Kostenlos starten →